(165) NOVEL INSIGHTS ON PERIOPERATIVE ANTIMICROBIAL PROPHYLAXIS PATTERNS FOR INFLATABLE PENILE PROSTHESIS: FINDINGS FROM A LARGE MULTINATIONAL COLLABORATIVE
Abstract Introduction Inflatable penile prosthesis (IPP) surgery is a well-established treatment for erectile dysfunction (ED). There is little information in the literature regarding the utilization of perioperative antimicrobial prophylaxis in primary and revision IPP surgeries. Objective We investigated the patterns of perioperative antimicrobial prophylaxis among a large multinational cohort of primary and revision IPP surgeries. Methods We conducted a retrospective analysis of 5,400 patients (4,187 primary IPP patients and 849 revision IPP patients) from our Prosthetic Urology Multi-Institutional Partnership (PUMP) institutions. Usage data for intravenous (IV), preoperative oral, and postoperative oral antimicrobials were analyzed. We specifically assessed patient profiles, antimicrobial selection, and antimicrobial duration. Multivariate statistical analyses were conducted to identify significant variations between primary and revision surgeries. Results For patients undergoing primary IPP placement, 81.9% received IV antibiotics for <24 hours whereas 18.1% received IV antibiotics for >24 hours. Preoperative oral antimicrobials were used in 59.4% of patients and 99.4% received postoperative oral antimicrobials. The overall infection rate for primary implants was 2%. Notably, quinolone administration shows a higher postoperative infection rate (11.4%) compared to gentamicin (1.9%), cephalosporin (0%), and vancomycin (1.0%). Multivariable regression analysis identifies factors such as a history of infection, diabetes, and priapism as predictors for postoperative infections. Furthermore, the study finds that perioperative antifungal use is associated with a decreased risk of infection. Conclusions This study provides valuable insights into the patterns of perioperative antimicrobial prophylaxis. Duration, type, and route of antibiotics given preoperatively or postoperatively do not affect postoperative infection rates among high volume prosthetic urologists. Giving IV antibiotics for more than 24 hours does not affect postoperative infection. Perioperative antifungals are a protective factor. Disclosure Any of the authors act as a consultant, employee or shareholder of an industry for: Coloplast, Clarus Therapeutics, Antares Pharma, Acerus.
Authors
- Daniar Osmonov (ORCID: https://orcid.org/0000-0002-0701-4259)
- So Hyun Park (ORCID: https://orcid.org/0000-0002-5283-4619)
- Hossein Sadeghi‐Nejad (ORCID: https://orcid.org/0000-0002-4032-8110)
- Daniel Swerdloff (ORCID: https://orcid.org/0000-0001-6302-3400)
- Robert Andrianne
- Koenraad van Renterghem (ORCID: https://orcid.org/0000-0001-5367-6651)
- Jay Simhan (ORCID: https://orcid.org/0000-0003-2262-7376)
- Ian Pearce (ORCID: https://orcid.org/0000-0002-7710-0531)
- Elia Abou Chawareb (ORCID: https://orcid.org/0000-0002-0757-896X)
- James M. Jones (ORCID: https://orcid.org/0000-0002-1413-2536)
- Vaibhav Modgil (ORCID: https://orcid.org/0009-0009-1517-6184)
- Adam Jones
- JM Hotaling
- Matthew Ziegelmann (ORCID: https://orcid.org/0000-0001-9974-3936)
- MS Gross
- A Suarez-Sarmiento
- G Hatzichristodoulou
- Maxime Sempels
- Justin Miller (ORCID: https://orcid.org/0000-0002-0562-5224)
- Lawrence C. Jenkins (ORCID: https://orcid.org/0000-0003-0125-673X)
- A Lentz
- P Perito
- B Azad (ORCID: https://orcid.org/0000-0002-2730-4034)
- TC Hsieh
- MAM Hammad
- J Warner
- DW Barham
- FA Yafi
- Kelli Gross
- AL Burnett
Institutions
- Dartmouth–Hitchcock Medical Center (US)
- Fox Chase Cancer Center (US)
- Brooke Army Medical Center (US)
- Mayo Clinic (US)
- Johns Hopkins University (US)
- University of Liège (BE)
- Duke University (US)
- University of California, Irvine (US)
- University of Utah (US)
- University of California San Diego (US)
- Manchester University NHS Foundation Trust (GB)
- Jessa Hospital (BE)
- University Hospital Schleswig-Holstein (DE)
- Martha-Maria Hospital (DE)
- New York University (US)
- University of Lübeck (DE)
Publication Details
- Journal
- The Journal of Sexual Medicine
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1093/jsxmed/qdae167.162
- Primary Topic
- Sexual function and dysfunction studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00